Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

510 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Detection of Novel Fusion Transcript VTI1A-CFAP46 in Hepatocellular Carcinoma.
Tsuge S, Saberi B, Cheng Y, Wang Z, Kim A, Luu H, Abraham JM, Ybanez MD, Hamilton JP, Selaru FM, Villacorta-Martin C, Schlesinger F, Philosophe B, Cameron AM, Zhu Q, Anders R, Gurakar A, Meltzer SJ. Tsuge S, et al. Among authors: luu h. Gastrointest Tumors. 2019 Aug;6(1-2):11-27. doi: 10.1159/000496795. Epub 2019 Apr 10. Gastrointest Tumors. 2019. PMID: 31602373 Free PMC article.
Role of nucleoside/nucleotide analogues and low-dose hepatitis B immune globülin in prophylaxis of hepatitis B recurrence among cadaveric liver transplant recipients.
Ajayi T, Luu H, Saberi B, Hamilton JP, Konduk BT, Özşeker B, Al Khalloufi K, Pustavoitau A, Philosophe B, Cameron AM, Gürakar A. Ajayi T, et al. Among authors: luu h. Turk J Gastroenterol. 2018 Jan;29(1):61-66. doi: 10.5152/tjg.2018.17595. Turk J Gastroenterol. 2018. PMID: 29391309 Free PMC article.
Accuracy of Milan, University of California San Francisco, and Up-To-7 Criteria in Predicting Tumor Recurrence Following Deceased-Donor Liver Transplant in Patients With Hepatocellular Carcinoma.
Saberi B, Garonzik-Wang J, Ma M, Ajayi T, Kim A, Luu H, Jakhete N, Pustavoitau A, Anders RA, Georgiades C, Kamel I, Ottmann S, Philosophe B, Cameron AM, Gurakar A. Saberi B, et al. Among authors: luu h. Exp Clin Transplant. 2020 Aug;18(4):463-469. doi: 10.6002/ect.2017.0288. Epub 2018 Aug 6. Exp Clin Transplant. 2020. PMID: 30084757 Free PMC article.
Urine DNA biomarkers for hepatocellular carcinoma screening.
Kim AK, Hamilton JP, Lin SY, Chang TT, Hann HW, Hu CT, Lou Y, Lin YJ, Gade TP, Park G, Luu H, Lee TJ, Wang J, Chen D, Goggins MG, Jain S, Song W, Su YH. Kim AK, et al. Among authors: luu h. Br J Cancer. 2022 Jun;126(10):1432-1438. doi: 10.1038/s41416-022-01706-9. Epub 2022 Jan 19. Br J Cancer. 2022. PMID: 35046521 Free PMC article.
Novel urine cell-free DNA methylation markers for hepatocellular carcinoma.
Lin SY, Xia W, Kim AK, Chen D, Schleyer S, Choi L, Wang Z, Hamilton JP, Luu H, Hann HW, Chang TT, Hu CT, Woodard A, Gade TP, Su YH. Lin SY, et al. Among authors: luu h. Sci Rep. 2023 Dec 7;13(1):21585. doi: 10.1038/s41598-023-48500-y. Sci Rep. 2023. PMID: 38062093 Free PMC article.
510 results